News

These Awards will establish 12 Cancer Nanotechnology Platform Partnerships.

Cedara will introduce a clinical product line named Cedara OncologyWorks at this year's ASTRO conference.

Using an enzyme called TdTase, engineers can vertically extend short DNA chains.

The studies aim at increasing the bioavailability of several new chemical entities in the human body.

NCL will characterize DNT's STARBURST™ dendrimers as macromolecular dendrimer-based MRI contrast agents.

Using the reagents from Tm Bioscience, PathGroup have developed an upgraded CF assay.

First year awards totaling $26.3 million will help establish seven Centers of Cancer Nanotechnology Excellence.

The NIH anticipates spending $150 million over five years to renew its Pharmacogenetics Research Network.

BioForce was awarded $500,000 to support commercialization of its award-winning NanoArrayer™ technology for production of ultraminiaturized biomedical tests and devices.

The cluster, called NanoBio, aims to foster the technological and economical development in the bioengineering field, taking advantage of the CEA’s 10-years experience in biochips and bioMEMS research.